TY - JOUR
T1 - Current developments in neurology, part I
T2 - Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis
AU - Gidal, Barry E.
AU - Wagner, Mary L.
AU - Privitera, Michael D.
AU - Dalmady-Israel, Christina
AU - Crismon, M. Lynn
AU - Fagan, Susan C.
AU - Graves, Nina M.
PY - 1996/11
Y1 - 1996/11
N2 - When caring for patients with disorders of the central nervous system such as migraine headaches, epilepsy, or MS, clinicians are faced with increasingly complex pharmacotherapeutic options. Pharmacotherapeutic strategies directed toward prevention, reversal, or cure of these diseases are hampered by an incomplete understanding of the underlying pathophysiology. In this decade of the brain, basic science research combined with difficult but necessary clinical trials may answer some seemingly overwhelming questions for these devastating illnesses.
AB - When caring for patients with disorders of the central nervous system such as migraine headaches, epilepsy, or MS, clinicians are faced with increasingly complex pharmacotherapeutic options. Pharmacotherapeutic strategies directed toward prevention, reversal, or cure of these diseases are hampered by an incomplete understanding of the underlying pathophysiology. In this decade of the brain, basic science research combined with difficult but necessary clinical trials may answer some seemingly overwhelming questions for these devastating illnesses.
UR - http://www.scopus.com/inward/record.url?scp=0029864514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029864514&partnerID=8YFLogxK
U2 - 10.1177/106002809603001112
DO - 10.1177/106002809603001112
M3 - Review article
C2 - 8913410
AN - SCOPUS:0029864514
SN - 1060-0280
VL - 30
SP - 1272
EP - 1276
JO - Annals of Pharmacotherapy
JF - Annals of Pharmacotherapy
IS - 11
ER -